New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
07:48 EDTDHR, A, PKIPerkinElmer, Agilent unit seen as potential Danaher targets, Bloomberg says
With Danaher (DHR) having recently lost out to private equity firms on buyout targets it was seeking, analysts at Janney Montgomery Scott speculated that the conglomerate could set its sights on targets such as PerkinElmer (PKI), Agilent's (A) life sciences unit, or an international target like Oxford Instruments of the U.K., said Bloomberg's "Real M&A" column. Citigroup analysts suggest Danaher could also consider a breakup instead of an acquisition, the report noted. Reference Link
News For DHR;A;PKI From The Last 14 Days
Check below for free stories on DHR;A;PKI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
11:01 EDTAAgilent signs co-marketing agreement with MRM Proteomics
Subscribe for More Information
July 23, 2014
13:39 EDTPKIThermo Fisher Q2 results bode well for PerkinElmer, Bruker, says Mizuho
Subscribe for More Information
July 18, 2014
14:44 EDTDHRDanaher weakness creates buying opportunity, says Argus
Subscribe for More Information
09:08 EDTDHRDanaher sell-off overdone, says Goldman
Subscribe for More Information
July 17, 2014
06:21 EDTPKIPerkinElmer initiated with a Buy at Citigroup
Target $55.
06:20 EDTAAgilent initiated with a Neutral at Citigroup
Target $64.
06:18 EDTDHRDanaher narrows FY14 EPS view to $3.67-$3.72, consensus $3.75
Subscribe for More Information
06:18 EDTDHRDanaher sees Q3 EPS 86c-89c, consensus 93c
Subscribe for More Information
06:04 EDTDHRDanaher reports Q2 EPS 95c, consensus 94c
Subscribe for More Information
July 16, 2014
16:05 EDTDHRDanaher to acquire Siemens Healthcare Diagnostics' clinical microbiology unit
Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (DHR), announced that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics (SIEGY). The microbiology business operates with an installed base of over 6,000 instruments globally. The transaction is expected to close in 1Q15.
15:27 EDTDHRNotable companies reporting before tomorrow's open
Subscribe for More Information
14:01 EDTDHRDanaher technical comments before earnings
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use